Claims against Dr Reddy's over Revlimid in US dismissedDr Reddy's Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medic...
29 Dec, 2022, 11.53 AM IST
Dr Reddy's Laboratories among other generic pharma companies in US to face antitrust litigation"The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and...
22 Nov, 2022, 05.31 PM IST
Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...
19 Oct, 2021, 12.22 PM IST
Oxford Covid-19 vaccine doing ‘everything expected', independent study findsThe experts say that the novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immun...
22 Oct, 2020, 07.22 PM IST
Syngene International joins global consortium of 19 healthcare organisations on COVID-19 testingA diverse group of companies with synergistic areas of expertise, including precision medicine, diagnostics, occupational health, pharmaceu...
01 Oct, 2020, 11.22 PM IST
Biocon arm widens partnership terms with Bristol-Myers SquibbAs part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristo...
14 Nov, 2017, 11.33 AM IST
UK speaker lauds Indian Diaspora's contribution to BritainJohn Bercow has asked the Indian community to build on its successes and achieve better representation in parliament by engaging more with ...
24 Apr, 2016, 07.58 PM IST
Dr Reddy's rejigs top deck as North America head quitsVora will be replaced by Alok Sonig, who is currently responsible for the Indian market and is a member of the management council at the co...
27 Aug, 2015, 10.15 AM IST
Bristol-Myers sues Dr Reddy's Laboratories for patent infringement in USBristol-Myers Squibb Company has filed patent infringement case against Dr Reddy's Laboratories over the cancer drug Ixempra.
28 Dec, 2012, 08.40 AM IST
- Dr Reddy's acquires GSK's US penicillin facility
Dr Reddy's Laboratories has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil bran...
30 Mar, 2011, 02.16 PM IST
- Bristol-Myers patent plea for HIV drug rejected
India has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...
11 Jan, 2011, 07.01 AM IST
- Dr Reddy’s buys GSK’s oral penicillin facility in US
Dr Reddy’s Laboratories, one of the country’s biggest drug firms, has bought GlaxoSmithKline’s oral penicillin facility and products in the...
24 Nov, 2010, 01.34 AM IST
- HC rejects BMS’ plea on sale of hepatitis B generic by Ranbaxy
The Delhi High Court (HC) has turned down Bristol-Myers Squibb’s (BMS) request to temporarily stop Ranbaxy from selling its generic version...
23 Sep, 2010, 02.15 AM IST
- Ranbaxy buys rights for 13 dermatology products
Ranbaxy Laboratories on Monday said it has acquired the US marketing rights for 13 dermatology products from Bristol-Myers Squibb Company (...
28 May, 2007, 03.05 PM IST
- Dr Reddy's may land a major role in Plavix patent play
With the block-the-sale request filed by Bristol-Myers Squibb (BMS) and partner Sanofi-Aventis against Apotex’s brazen launch of generic ‘P...
18 Aug, 2006, 12.43 AM IST
- Plavix Accord: Bristol-Myers, Sanofi face criminal probe
Sanofi-Aventis said the US started a criminal probe of a plan to keep a generic version of their top-selling blood-thinner Plavix off the m...
29 Jul, 2006, 12.25 AM IST
- Ranbaxy gets USFDA nod for antibiotic
Ranbaxy Laboratories Limited (RLL) on Friday said it had received approval from the US Food and Drug Administration to manufacture and mark...
30 Jun, 2006, 10.00 PM IST